The conference presents the latest science behind living well with lung cancer through educational sessions, expert panels, and special breakout groups
LUNGevity’s third annual International Lung Cancer Survivorship Conference (ILCSC) is coming up on July 15 and 16. This fully virtual conference provides opportunities for lung cancer survivors, caregivers, and advocates to hear from world-renowned researchers on the latest treatments, learn about ways to manage your lung cancer and treatment journey, and find hope in today’s scientific progress.
The goal of ILCSC is to help build a better understanding of the science behind the disease in order to enhance communication with the patient’s healthcare team and to facilitate more active participation in shared healthcare decision-making. We are excited to provide this sneak peek at some of the educational and empowering sessions you can expect to see this year!
Optimizing Your Lung Cancer Care No Matter Where You Live
Hear from clinicians with experience in major academic medical centers as well as community cancer centers on how, despite some differences in the structure of their institutions, patients can still receive the optimal standard of care.
Immuno-Oncology: Which I/O Is Right For Me?
With more immunotherapy treatment options approved for lung cancer than ever before, knowing the right questions to ask about I/O is critical. Dr. Julie Brahmer, Director of the Thoracic Oncology Program at the Johns Hopkins Kimmel Cancer Center-Bayview and member of LUNGevity’s Scientific Advisory Board, will present a primer on advancements in this rapidly growing field.
Ask The Experts
Join expert clinicians for an open discussion of the most pressing questions facing the lung cancer community today. Panelists include:
- Dr. Patrick Forde, Director of the Thoracic Cancer Clinical Research Program at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Dr. Paul Paik, Clinical Director of Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center
- Dr. Melissa Johnson, Director of the Lung Cancer Research Program at Sarah Cannon Research Institute
- Dr. Vivek Subbiah, Clinical Medical Director of the Clinical Center for Targeted Therapy, Cancer Medicine Division, at The University of Texas MD Anderson Cancer Center
Other featured sessions will include the benefits of pulmonary rehab, a Q&A on medical marijuana, biomarker- and treatment-specific Ask the Expert breakouts co-led by clinicians and experienced patient advocates, plus updates on LUNGevity’s programs and resources. Registration is free and all sessions will be recorded and available to view for 90 days after the live broadcast, from July 21 to October 19, 2022.